drugset / Trial / NCT03742180
Sublingual Ketorolac Compared to Intranasal Dexmedetomidine for Postoperative Analgesia in Pediatric Patients Undergoing Bilateral Myringotomy
Withdrawn
Mansoura University
RandomizedParallel-groupDouble-blindSupportive care
Summary
The investigators aim to compare intranasal dexmedetomidine in a dose of 1ug.kg-1 with sublingual ketorolac in a dose of 1mg.kg-1 on postoperative behaviour in those children undergoing BMT during their PACU stay
Timeline
- Start
- 2018-01-01
- Primary completion
- 2019-04-30
- Completion
- 2019-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intranasal |
| Comparator | Ketorolac | Other / unclassified | 0.5 mg/kg | Other |
Indications
No indication recorded.